Adaptimmune Therapeutics plc (473A) — Free Cash Flow Generation Index

Latest as of June 2024: 0.98x

Adaptimmune Therapeutics plc (473A) has a Free Cash Flow Generation Index of 0.98x as of June 2024. Free cash flow of €46.65 Million represents 1% of operating cash flow (€47.40 Million). Explore Adaptimmune Therapeutics plc (473A) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.98x

Free Cash Flow / Operating CF

Free Cash Flow

€46.65 Million

EUR

Operating Cash Flow

€47.40 Million

EUR

Capital Expenditures

€754.00K

EUR

Adaptimmune Therapeutics plc Free Cash Flow Generation Index (2021–2021)

Historical FCF Generation Index trend for Adaptimmune Therapeutics plc across 1 annual periods. For the full cash flow conversion analysis, see Adaptimmune Therapeutics plc cash flow conversion.

Annual Free Cash Flow Generation for Adaptimmune Therapeutics plc (2021–2021)

Year-by-year Free Cash Flow Generation Index for Adaptimmune Therapeutics plc. Check cash flow reinvestment rate of Adaptimmune Therapeutics plc to assess the company's total reinvestment commitment from operating cash flow.

Year	FCG Index	Free Cash Flow (EUR)	Operating CF	Capital Expenditures	YoY Change
2021	0.18x	€1.95 Million	€10.73 Million	€8.57 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).